Imagyn Gets Clearance
- Share via
LAGUNA NIGUEL — Imagyn Medical Inc. said Wednesday it has received clearance from the Food and Drug Administration to market its MicroLap Gold microlaparoscope for the diagnosis and treatment of pelvic pain, infertility and tubal ligation. Imagyn said it will begin shipments of MicroLap Gold to U.S. Surgical Corp. in the second quarter. Imagyn has an agreement for U.S. Surgical to distribute the MicroLap products.
Imagyn Medical designs, develops and markets micro-invasive device systems for the diagnosis and treatment of gynecological and reproductive disorders. Its stock rose 12.5 cents to $7.875 Wednesday in Nasdaq trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
